Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Globe Newswire•17/08/2026•16:01 ET
0
Whiz Insights
Get started
Create a free account to read the full story.